CollPlant Biotechnologies (CLGN) Assets Growth (5y) (2022 - 2025)

CollPlant Biotechnologies (CLGN) Assets Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 CollPlant Biotechnologies 4.63 Mn 4.63 Mn -243,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.10%
Sep 30, 2025 1.98%
Jun 30, 2025 9.76%
Dec 31, 2024 11.72%
Sep 30, 2024 -71.92%
Jun 30, 2024 22.71%
Mar 31, 2024 -69.59%
Dec 31, 2023 31.28%
Sep 30, 2023 -63.98%
Jun 30, 2023 46.04%
Mar 31, 2023 7.67%
Dec 31, 2022 36.10%